Lipoatrophy: a non-reversible complication of subcutaneous interferon-beta 1a treatment of multiple sclerosis.
Beiske
Antonie Giaever
AG
Myhr
Kjell-Morten
KM
D000328:Adult; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous / Q000379:methods; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000009:adverse effects* / Q000627:therapeutic use; D008060:Lipodystrophy / Q000139:chemically induced*; D009103:Multiple Sclerosis / Q000188:drug therapy
D016899:Interferon-beta; D000068556:Interferon beta-1a